Alkem Labs Receives GST Demand Order of ₹3.83 Crore for FY18-20
Alkem Laboratories received a GST demand order for ₹3.83 crore plus penalty for FY18-20 from Chennai authorities. The company disputes the demand, citing correct tax discharge, and plans to appeal. No material financial or operational impact is expected.
The company explicitly stated that there is no material impact on financial, operational, or other activities, and the amount of the demand is relatively small compared to the company's overall revenue.
The company received a GST demand order, which is negative. However, they do not agree with the demand and plan to appeal, and state there is no material impact, making the overall sentiment neutral.
Alkem Laboratories Limited announced on January 13, 2026, that it has received an order from the Commissioner of GST & Central Excise (Appeals - II) in Chennai. The order pertains to the period of 2017-2018 to 2019-2020, demanding a Goods and Services Tax (GST) of ₹3,83,45,920, along with applicable interest and a penalty of ₹38,34,592 under the CGST and SGST Acts.
The company stated that the demand order alleges short payment of taxes, which Alkem Laboratories believes is incorrect as the taxes were appropriately discharged. The company does not agree with the demand and intends to contest it by filing an appeal.
Alkem Laboratories has indicated that there is no material impact on its financial, operational, or other activities as a result of this order. The company is in the process of taking appropriate action, including filing an appeal.
What to do with a filing like this
Alkem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alkem Laboratories Limited. Read the original for the full detail.